Skip to main content
Top
Published in: AIDS and Behavior 7/2011

01-10-2011 | Original Paper

Poverty, Hunger, Education, and Residential Status Impact Survival in HIV

Authors: James McMahon, Christine Wanke, Norma Terrin, Sally Skinner, Tamsin Knox

Published in: AIDS and Behavior | Issue 7/2011

Login to get access

Abstract

Despite combination antiretroviral therapy (ART), HIV infected people have higher mortality than non-infected. Lower socioeconomic status (SES) predicts higher mortality in many chronic illnesses but data in people with HIV is limited. We evaluated 878 HIV infected individuals followed from 1995 to 2005. Cox proportional hazards for all-cause mortality were estimated for SES measures and other factors. Mixed effects analyses examined how SES impacts factors predicting death. The 200 who died were older, had lower CD4 counts, and higher viral loads (VL). Age, transmission category, education, albumin, CD4 counts, VL, hunger, and poverty predicted death in univariate analyses; age, CD4 counts, albumin, VL, and poverty in the multivariable model. Mixed models showed associations between (1) CD4 counts with education and hunger; (2) albumin with education, homelessness, and poverty; and (3) VL with education and hunger. SES contributes to mortality in HIV infected persons directly and indirectly, and should be a target of health policy in this population.
Literature
1.
go back to reference Huisman M, Kunst AE, Bopp M, Borgan JK, Borrell C, Costa G, et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet. 2005;365(9458):493–500.PubMed Huisman M, Kunst AE, Bopp M, Borgan JK, Borrell C, Costa G, et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet. 2005;365(9458):493–500.PubMed
2.
go back to reference Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347(20):1585–92.PubMedCrossRef Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347(20):1585–92.PubMedCrossRef
3.
go back to reference Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–9.PubMedCrossRef Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–9.PubMedCrossRef
4.
go back to reference Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337(11):725–33.PubMedCrossRef Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337(11):725–33.PubMedCrossRef
5.
go back to reference Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV outpatient study investigators. N Engl J Med. 1998;338(13):853–60.PubMedCrossRef Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV outpatient study investigators. N Engl J Med. 1998;338(13):853–60.PubMedCrossRef
6.
go back to reference Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d’Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–9.PubMedCrossRef Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d’Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–9.PubMedCrossRef
7.
go back to reference Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995;333(12):751–6.PubMedCrossRef Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995;333(12):751–6.PubMedCrossRef
8.
go back to reference Katz MH, Hsu L, Lingo M, Woelffer G, Schwarcz SK. Impact of socioeconomic status on survival with AIDS. Am J Epidemiol. 1998;148(3):282–91.PubMed Katz MH, Hsu L, Lingo M, Woelffer G, Schwarcz SK. Impact of socioeconomic status on survival with AIDS. Am J Epidemiol. 1998;148(3):282–91.PubMed
9.
go back to reference Rapiti E, Porta D, Forastiere F, Fusco D, Perucci CA. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy Lazio AIDS Surveillance Collaborative Group. Epidemiol Cambridge Mass. 2000;11(5):496–501. Rapiti E, Porta D, Forastiere F, Fusco D, Perucci CA. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy Lazio AIDS Surveillance Collaborative Group. Epidemiol Cambridge Mass. 2000;11(5):496–501.
10.
go back to reference Fordyce EJ, Singh TP, Nash D, Gallagher B, Forlenza S. Survival rates in NYC in the era of combination ART. J Acquir Immune Defic Syndr. 2002;30(1):111–8. (May 1).PubMed Fordyce EJ, Singh TP, Nash D, Gallagher B, Forlenza S. Survival rates in NYC in the era of combination ART. J Acquir Immune Defic Syndr. 2002;30(1):111–8. (May 1).PubMed
11.
go back to reference Hogg RS, Strathdee SA, Craib KJ, O’Shaughnessy MV, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet. 1994;344(8930):1120–4.PubMedCrossRef Hogg RS, Strathdee SA, Craib KJ, O’Shaughnessy MV, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet. 1994;344(8930):1120–4.PubMedCrossRef
12.
go back to reference Schechter MT, Hogg RS, Aylward B, Craib KJ, Le TN, Montaner JS. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. J Clin Epidemiol. 1994;47(1):59–67.PubMedCrossRef Schechter MT, Hogg RS, Aylward B, Craib KJ, Le TN, Montaner JS. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. J Clin Epidemiol. 1994;47(1):59–67.PubMedCrossRef
13.
go back to reference McDavid Harrison K, Ling Q, Song R, Hall HI. County-level socioeconomic status and survival after HIV diagnosis, United States. Ann Epidemiol. 2008;18(12):919–27.PubMedCrossRef McDavid Harrison K, Ling Q, Song R, Hall HI. County-level socioeconomic status and survival after HIV diagnosis, United States. Ann Epidemiol. 2008;18(12):919–27.PubMedCrossRef
14.
go back to reference McFarland W, Chen S, Hsu L, Schwarcz S, Katz M. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr. 2003;33(1):96–103. (May 1).PubMedCrossRef McFarland W, Chen S, Hsu L, Schwarcz S, Katz M. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr. 2003;33(1):96–103. (May 1).PubMedCrossRef
15.
go back to reference Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS. 2002;16(15):2065–72. (Oct 18).PubMedCrossRef Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS. 2002;16(15):2065–72. (Oct 18).PubMedCrossRef
16.
go back to reference Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, Zhang W, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500–5. (Apr 1).PubMedCrossRef Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, Zhang W, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500–5. (Apr 1).PubMedCrossRef
17.
go back to reference Cunningham WE, Hays RD, Duan N, Andersen R, Nakazono TT, Bozzette SA, et al. The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. J Health Care Poor Underserved. 2005;16(4):655–76.PubMed Cunningham WE, Hays RD, Duan N, Andersen R, Nakazono TT, Bozzette SA, et al. The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. J Health Care Poor Underserved. 2005;16(4):655–76.PubMed
18.
go back to reference Forrester JE, Spiegelman D, Woods M, Knox TA, Fauntleroy JM, Gorbach SL. Weight and body composition in a cohort of HIV-positive men and women. Public Health Nutr. 2001;4(3):743–7.PubMedCrossRef Forrester JE, Spiegelman D, Woods M, Knox TA, Fauntleroy JM, Gorbach SL. Weight and body composition in a cohort of HIV-positive men and women. Public Health Nutr. 2001;4(3):743–7.PubMedCrossRef
19.
go back to reference Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95(12):3482–9.PubMedCrossRef Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95(12):3482–9.PubMedCrossRef
22.
go back to reference Radimer KL, Olson CM, Campbell CC. Development of indicators to assess hunger. J Nutr. 1990;120(Suppl 11):1544–8.PubMed Radimer KL, Olson CM, Campbell CC. Development of indicators to assess hunger. J Nutr. 1990;120(Suppl 11):1544–8.PubMed
23.
go back to reference Kendall A, Olson CM, Frongillo EA Jr. Validation of the Radimer/Cornell measures of hunger and food insecurity. J Nutr. 1995;125(11):2793–801.PubMed Kendall A, Olson CM, Frongillo EA Jr. Validation of the Radimer/Cornell measures of hunger and food insecurity. J Nutr. 1995;125(11):2793–801.PubMed
24.
go back to reference Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26(8):775–89.PubMedCrossRef Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26(8):775–89.PubMedCrossRef
25.
go back to reference Who is currently living with HIV/AIDS?—Detailed data tables and technical notes: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007. Who is currently living with HIV/AIDS?—Detailed data tables and technical notes: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007.
26.
go back to reference Massachusetts HIV/AIDS Data Fact Sheet. Who is most at risk of HIV infection?: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007. Massachusetts HIV/AIDS Data Fact Sheet. Who is most at risk of HIV infection?: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007.
27.
go back to reference 2007 Rhode Island HIV/AIDS Epidemiologic Profile With Surrogate Data: Rhode Island Department of Health. Division of Community Family Health and Equity. Office of HIV/AIDS & Viral Hepatitis August 2008. 2007 Rhode Island HIV/AIDS Epidemiologic Profile With Surrogate Data: Rhode Island Department of Health. Division of Community Family Health and Equity. Office of HIV/AIDS & Viral Hepatitis August 2008.
28.
go back to reference Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women’s interagency HIV study. AIDS. 1999;13(13):1717–26.PubMedCrossRef Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women’s interagency HIV study. AIDS. 1999;13(13):1717–26.PubMedCrossRef
29.
go back to reference Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, et al. Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr. 2003;33(1):66–73. (May 1).PubMedCrossRef Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, et al. Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr. 2003;33(1):66–73. (May 1).PubMedCrossRef
30.
go back to reference Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men Multicenter AIDS Cohort Study. J Infect Dis. 2000;181(3):872–80.PubMedCrossRef Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men Multicenter AIDS Cohort Study. J Infect Dis. 2000;181(3):872–80.PubMedCrossRef
34.
go back to reference Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS reports. 2007;4(4):181–6.PubMedCrossRef Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS reports. 2007;4(4):181–6.PubMedCrossRef
35.
go back to reference Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses. 2006;22(1):14–21.PubMedCrossRef Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses. 2006;22(1):14–21.PubMedCrossRef
36.
go back to reference Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946–54.PubMed Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946–54.PubMed
37.
go back to reference Mason JB. Nutritional Assessment and Management of the Malnourished Patient,Eighth ed. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. W B Saunders Company; 2006. Mason JB. Nutritional Assessment and Management of the Malnourished Patient,Eighth ed. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. W B Saunders Company; 2006.
38.
go back to reference Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS care. 2004;16(Suppl 1):S22–42.PubMedCrossRef Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS care. 2004;16(Suppl 1):S22–42.PubMedCrossRef
39.
go back to reference Diaz T, Chu SY, Buehler JW, Boyd D, Checko PJ, Conti L, et al. Socioeconomic differences among people with AIDS: results from a Multistate Surveillance Project. Am J Prev Med. 1994;10(4):217–22.PubMed Diaz T, Chu SY, Buehler JW, Boyd D, Checko PJ, Conti L, et al. Socioeconomic differences among people with AIDS: results from a Multistate Surveillance Project. Am J Prev Med. 1994;10(4):217–22.PubMed
40.
go back to reference Hankins C, Tran T, Hum L, Laberge C, Lapointe N, Lepine D, et al. Socioeconomic geographical links to human immunodeficiency virus seroprevalence among childbearing women in Montreal, 1989–1993. Int J Epidemiol. 1998;27(4):691–7.PubMedCrossRef Hankins C, Tran T, Hum L, Laberge C, Lapointe N, Lepine D, et al. Socioeconomic geographical links to human immunodeficiency virus seroprevalence among childbearing women in Montreal, 1989–1993. Int J Epidemiol. 1998;27(4):691–7.PubMedCrossRef
41.
go back to reference Zierler S, Krieger N, Tang Y, Coady W, Siegfried E, DeMaria A, et al. Economic deprivation and AIDS incidence in Massachusetts. Am J Public Health. 2000;90(7):1064–73.PubMedCrossRef Zierler S, Krieger N, Tang Y, Coady W, Siegfried E, DeMaria A, et al. Economic deprivation and AIDS incidence in Massachusetts. Am J Public Health. 2000;90(7):1064–73.PubMedCrossRef
42.
go back to reference El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96.PubMedCrossRef El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96.PubMedCrossRef
43.
go back to reference Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197(8):1133–44.PubMedCrossRef Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197(8):1133–44.PubMedCrossRef
45.
go back to reference Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. Jama. 1998;280(6):547–9.PubMedCrossRef Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. Jama. 1998;280(6):547–9.PubMedCrossRef
46.
go back to reference Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94(3):167–73.PubMed Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94(3):167–73.PubMed
47.
go back to reference Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18(13):1835–43.PubMedCrossRef Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18(13):1835–43.PubMedCrossRef
48.
go back to reference Fox CS, Evans JC, Larson MG, Lloyd-Jones DM, O’Donnell CJ, Sorlie PD, et al. A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am J Cardiol. 2005;95(7):856–9.PubMedCrossRef Fox CS, Evans JC, Larson MG, Lloyd-Jones DM, O’Donnell CJ, Sorlie PD, et al. A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am J Cardiol. 2005;95(7):856–9.PubMedCrossRef
Metadata
Title
Poverty, Hunger, Education, and Residential Status Impact Survival in HIV
Authors
James McMahon
Christine Wanke
Norma Terrin
Sally Skinner
Tamsin Knox
Publication date
01-10-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 7/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9759-z

Other articles of this Issue 7/2011

AIDS and Behavior 7/2011 Go to the issue